• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

WVU Medicine, Interwell Health Partner to Improve Kidney Care in West Virginia

by Jasmine Pennic 03/28/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
WVU Medicine, Interwell Health Partner to Improve Kidney Care in West Virginia

What You Should Know:

– WVU Medicine announced a new partnership with Interwell Health to focus on improving care for patients with chronic kidney disease (CKD) in West Virginia.

– The strategic partnership aims to leverage population health approaches and cutting-edge technology to deliver better outcomes and reduce healthcare costs.

Addressing West Virginia’s CKD Crisis

According to the Centers for Disease Control and Prevention (CDC), West Virginia has the highest mortality rate for CKD patients in the nation. Interwell partners with physicians and healthcare providers to implement a population health approach to kidney care. This approach focuses on managing the health of an entire patient population, not just individual cases.  This partnership will see WVU Medicine nephrologists join Interwell’s network and leverage their expertise in value-based care.

Benefits for WVU Medicine and Patients

This partnership offers significant advantages for both WVU Medicine and its patients:

– Improved patient outcomes: By focusing on preventative measures and early intervention, WVU Medicine can slow disease progression and improve the overall health of CKD patients.

– Reduced healthcare costs: Interwell’s value-based care model emphasizes proactive care management, potentially leading to fewer hospitalizations and lower overall healthcare costs.

– Data-driven decision making: Utilizing data analytics and machine learning, WVU Medicine can personalize treatment plans and optimize care delivery for CKD patients.

– Collaboration and Best Practices: WVU Medicine gains access to Interwell’s national network of nephrologists, fostering collaboration and knowledge sharing to improve care for West Virginia residents.

“This partnership with Interwell opens the door to better care for our patients,” Rebecca Schmidt, D.O., WVU Medicine nephrologist said. “By approaching kidney disease from a population health perspective, we can use machine learning and other technologies to examine the progression of disease and use that data to implement more effective treatment plans. We understand that progress cannot happen in a vacuum, and Interwell presents the opportunity to collaborate with others on best practices and use this collaboration to help better the lives of West Virginia patients with kidney disease.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |